Skandinaviska Enskilda Banken (SEB)
BCYC

Skandinaviska Enskilda Banken (SEB)’s Bicycle Therapeutics BCYC Stock Holding History

Skandinaviska Enskilda Banken (SEB)’s Portfolio BCYC Stock Details BCYC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-42,729
Closed -$297K – 802
2025
Q2 		$297K Hold
42,729
– – ﹤0.01% 733
2025
Q1 		$363K Hold
42,729
– – ﹤0.01% 717
2024
Q4 		$603K Hold
42,729
– – ﹤0.01% 702
2024
Q3 		$969K Hold
42,729
– – ﹤0.01% 674
2024
Q2 		$866K Hold
42,729
– – ﹤0.01% 651
2024
Q1 		$1.06M Buy
+42,729
New +$908K 0.01% 655

Other funds holding BCYC

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $750M AUM 127.27% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.91B AUM 12.68% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $22.2B AUM 58.34% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

Skandinaviska Enskilda Banken (SEB)'s BCYC Position: Q3 2025 in Review

Skandinaviska Enskilda Banken (SEB) sold out of Bicycle Therapeutics (BCYC) in Q3 2025, closing a stake of 42,729 shares — an estimated $297K sold.

Skandinaviska Enskilda Banken (SEB) first reported a position in BCYC in Q1 2024 and held it in 6 quarters. The position peaked at $1.06M in Q1 2024. 99 funds tracked by Wall St. Rank hold BCYC as of Q3 2025.

  • Skandinaviska Enskilda Banken (SEB) reported no remaining Bicycle Therapeutics position as of Q3 2025 after selling out during the quarter.
  • Skandinaviska Enskilda Banken (SEB) sold 42,729 Bicycle Therapeutics shares in Q3 2025, an estimated $297K.
  • Skandinaviska Enskilda Banken (SEB) first reported a position in Bicycle Therapeutics in Q1 2024 and held it in 6 quarters.
  • Skandinaviska Enskilda Banken (SEB)'s Bicycle Therapeutics position peaked at $1.06M in Q1 2024.
  • 99 funds tracked by Wall St. Rank held Bicycle Therapeutics as of Q3 2025.

Based on Skandinaviska Enskilda Banken (SEB)'s 13F filing for Q3 2025, filed 7 Nov 2025.